French national cohort of first use of dalbavancin: A high proportion of off-label use

Author:

Dinh AurélienORCID,Duran Clara,Pavese Patricia,Khatchatourian Lydie,Monnin Boris,Bleibtreu Alexandre,Denis Eric,Etienne Cédric,Rouanes Nicolas,Mahieu Rafael,Bouchand Frédérique,Davido BenjaminORCID,Lotte Romain,Cabaret Philippe,Camou Fabrice,Chavanet Pascal,Assi Assi,Limonta SilviaORCID,Lechiche Catherine,Riou Raphaëlle,Courjon JohanORCID,Illes Gabriela,Lacassin-Beller Flore,Senneville Eric,Adjodah Chandra,Baclet Nicolas,Bouchard Odile,Boutoille David,Brunin Guillaume,Carbognani Daniel,Delobel Pierre,Ferrand Hélène,Imbert Yves,Leautez-Nainville Sophie,Le Moing Vincent,Loutfi Bouchra,Mrozek Natacha,Rouzic Nicolas,Talarmin Jean-Philippe,Tattevin Pierre,Weyrich Pierre

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference17 articles.

1. US Food and Drug Administration (FDA). DALVANCETM highlights of prescribing information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021883s000lbl.pdf[accessed 10 May 2019].

2. European Medicines Agency (EMA). Xydalba summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002840/WC500183869.pdf [accessed 10 May 2019].

3. In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic;Candiani;J Antimicrob Chemother,1999

4. Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates;Streit;Diagn Microbiol Infect Dis,2004

5. Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety;Rappo;Open Forum Infect Dis,2019

Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3